AI-Native Clinical Platform Telepatia Secures $33M Series A to Scale Across Latin America
São Paulo-based healthtech startup Telepatia has raised $33 million in a Series A round led by Andreessen Horowitz to expand its AI-powered clinical documentation and decision-support platform.
Telepatia, an AI-native clinical platform based in São Paulo, Brazil, has officially closed a $33 million Series A funding round. The investment was led by Andreessen Horowitz, with notable participation from industry heavyweights including Palantir CTO Shyam Sankar, Rappi founder Simón Borrero, and Nubank founder David Vélez.
Since its launch in 2025, Telepatia has focused on integrating AI-driven documentation and clinical decision support into healthcare systems. The platform is designed to alleviate administrative burdens for clinicians by automating documentation and providing real-time decision support. Currently, the technology is deployed across more than 25 hospital systems throughout Brazil, Colombia, and Mexico.
The newly secured capital will be directed toward scaling the company's operations across Latin America and further developing its suite of AI healthcare assistants. This includes expanding the capabilities of its AI-powered doctors, nurses, and auditors, which aim to improve overall clinical productivity and reduce medical errors in high-pressure hospital environments.
INTELLIGENCE BRIEF
WHY IT MATTERS
This funding highlights the growing investor appetite for AI-native solutions that solve specific, high-stakes operational challenges in healthcare. For the Turkish ecosystem, it serves as a benchmark for how specialized AI platforms can successfully scale across regional markets by addressing universal pain points like clinical administrative burnout.
WHO IS INVOLVED
Telepatia, Andreessen Horowitz, Shyam Sankar, Simón Borrero, David Vélez
MARKET IMPACT
The investment underscores a shift toward 'AI-native' healthcare platforms that prioritize clinical decision support over general administrative tools. It suggests that startups capable of demonstrating measurable reductions in medical errors and administrative overhead will continue to attract significant institutional backing.
This story was drafted with AI assistance and reviewed by TurkSpark editors before publication. Facts, figures, and names may be inaccurate — verify important details independently.
Swiss Fintech Range Secures $8.3 Million Series A for Hybrid Payment Infrastructure
Read
Dream, a Sovereign AI and Cyber Defence Startup, Secures $260 Million Funding Round
Read